Literature DB >> 9631

Effect of propranolol on mortality in patients with angina.

D M Lambert.   

Abstract

Two hundred and seventeen patients from general practice suffering from angina pectoris were studied over a three year period; 91 patients had beta-blocker treatment, the other 126 did not. The two groups were comparable for age, sex, blood pressure and length of history of angina. The frequency of infarction and mortality from infarction in the two groups was compared. The annual infarct rate in the 126 patients not treated with beta-blockers is shown to be more than three times the rate in the 91 patients treated by beta-blockers. The annual death rate from myocardial infarction is almost four times greater in the group not treated by beta-blockers compared with the beta-blocked group. It is concluded that this provides further evidence that treatment which includes beta-blockade in patients suffering from ischamic heart disease reduces the risk of myocardial infarction and death.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9631      PMCID: PMC2496222     

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology.

Authors:  M P Stapleton
Journal:  Tex Heart Inst J       Date:  1997

Review 2.  The medical treatment of angina pectoris.

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1987-12

3.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

4.  Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.

Authors:  A Markel; J G Brook; Y Levy; M Aviram; M B Youdim
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

5.  The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline.

Authors:  E Gille; H Lemoine; B Ehle; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.